Combo Therapy Boosts Response in Uncontrolled Gout
(MedPage Today) -- The addition of an immunomodulating agent to pegloticase (Krystexxa) among patients with uncontrolled gout significantly improved response rates, a systematic literature review found.
In a cohort of patients whose gout had been...
Read more »